XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 547,641 $ 419,486
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 357,622 391,775
Amortization of deferred financing costs 5,651 7,739
Non-cash lease expense 6,447 945
Non-cash interest expense related to amortization of discount on unsecured senior notes, net 23,083 21,558
Compensation expense related to share-based awards 15,679 6,192
Accrual of interest income added to principal of debt securities and notes receivable (16,421) (16,100)
(Gain) loss on real estate assets held for sale and sold, net (34,897) 54,659
Distributions from unconsolidated real estate ventures 17,910 14,540
Changes in operating assets and liabilities:    
Other assets 27,003 (3,463)
Accounts payable and accrued expenses 77,529 42,669
Other liabilities (1,981) 70,800
Net cash provided by operating activities 1,025,265 1,010,800
Cash flows from investing activities:    
Acquisition of real estate assets and improvements (464,517) (157,329)
Development and redevelopment of real estate assets (79,560) (69,384)
Proceeds from sale of real estate assets 133,206 0
Investment in unconsolidated real estate entities (113,285) (10,789)
Return of investment in unconsolidated real estate ventures 200,000 4,200
Issuance of notes receivable (360,406) (569,268)
Payments received on notes receivable 46,338 47,455
Proceeds from sale of notes receivable 32,371 0
Purchase of equipment and fixtures (8,402) (9,652)
Net cash used in investing activities (614,255) (764,767)
Cash flows from financing activities:    
Proceeds from unsecured term loans, senior notes, revolving lines of credit and commercial paper 6,440,431 3,263,470
Principal payments on unsecured term loans, senior notes, revolving lines of credit and commercial paper (6,974,943) (3,407,382)
Proceeds from issuance of public bonds, net 850,000 600,000
Deferred financing costs (13,373) (5,719)
Repurchase of common stock (8,615) 0
Proceeds from share issuances 0 366
Redemption of Operating Partnership units for cash (279) 0
Offering costs associated with shelf registration 0 (494)
Dividends paid on common stock (688,085) (687,636)
Distributions to noncontrolling interests, net of contributions (30,761) (32,177)
Net cash used in financing activities (425,625) (269,572)
Net decrease in cash, cash equivalents, and restricted cash (14,615) (23,539)
Cash, cash equivalents, and restricted cash, beginning of the period 143,303 105,083
Cash, cash equivalents, and restricted cash, end of the period 128,688 81,544
Cash and equivalents 125,045 76,973
Restricted cash included in other assets 3,643 4,571
Cash, cash equivalents, and restricted cash 128,688 81,544
Supplemental schedule of cash flow information    
Interest paid 283,419 230,242
Income taxes paid 23,955 22,034
Redemption of Operating Partnership units held by noncontrolling interests for common stock    
Noncontrolling interests in Operating Partnership (26,218) (54,491)
Common stock and paid-in capital 26,218 54,491
Acquisition and establishment of operating lease right of use assets and lease liabilities    
Real estate assets - operating lease right-of-use assets 419 0
Operating lease liabilities (419) 0
Acquisitions of real estate assets    
Real estate assets, net 111,984 0
Value of OP units issued (5,878) 0
Value of investment in consolidated real estate ventures (105,471) 0
Net liabilities assumed (635) 0
Accrued construction costs and capital expenditures    
Acquisition of real estate assets 14,014 4,754
Accounts payable and accrued expenses $ (14,014) $ (4,754)